Vaccination for Coronavirus Disease 2019: Opportunity, Hope, and Challenges

Gatot Soegiarto, - (2020) Vaccination for Coronavirus Disease 2019: Opportunity, Hope, and Challenges. New Armenian Medical Journal, 14 (4). pp. 58-66. ISSN 18290825

[img] Text (Artikel)
Artikel 4.pdf

Download (1MB)
[img] Text (Karil)
Karil Artikel 4.pdf

Download (651kB)
[img] Text (Similarity)
Turnitin Artikel 4.pdf

Download (3MB)
[img] Text (Bukti Korespondensi)
Bukti Korespondensi.pdf

Download (359kB)
Official URL: https://ysmu.am/website/documentation/files/13cc7e...

Abstract

COVID-19 continues to become a global threat. The development of COVID-19 vaccine has a potential to induce long-lasting cellular and humoral immunity and ending this pandemic. Currently, there are 213 vaccines in development, with 66 in clinical trials and 9 in phase III. In one hand the vaccines are developed using novel vaccine platforms including DNA and mRNA based, antigen-presenting cell, viral vector, protein or peptide-based, inactivated virus, and live attenuated virus platform. Each of these platforms has its own strength and weakness; however, they generally enable the vaccine to be developed safely, more quickly, and easier to upscale. In the other hand, the demand for COVID-19 vaccine has led to the development of vaccine being fast-tracked. Concerns are being raised for the efficacy, safety, equitability, and acceptance of these vaccines. Many are worried about the possibility of antibody-dependent enhancement that may worsen the recipient’s condition. Vaccine design therefore should take into account previous experience with vaccine-associated disease enhancement. Researchers should adhere to stringent standards of safety and efficacy when conducting vaccine’s clinical trials. Accelerated trials should also adhere to the Declaration of Helsinki for the ethics of medical research. Global partnership for vaccine development and equitable distribution is also needed to prevent resurgences of cases. Finally, there is a need to combat misinformation and distrust of COVID-19 vaccine in the eye of the general public.

Item Type: Article
Uncontrolled Keywords: SARS-CoV-2, COVID-19, vaccine, safety, efficacy
Subjects: R Medicine > R Medicine (General)
R Medicine > RC Internal medicine
Divisions: 01. Fakultas Kedokteran > Ilmu Penyakit Dalam
Creators:
CreatorsNIM
Gatot Soegiarto, -NIDN8888210016
Depositing User: arys fk
Date Deposited: 23 Oct 2022 13:36
Last Modified: 24 Dec 2022 11:51
URI: http://repository.unair.ac.id/id/eprint/118313
Sosial Share:

Actions (login required)

View Item View Item